Partner at Fasken
Serge Lapointe is a registered patent agent in both Canada and the United States. He has extensive experience obtaining patent protection in the life sciences sector in Canada, the United States and abroad. He specialises in drafting patent applications and preparing opinions on patent validity and infringement for the biotechnology, pharmaceutical and chemical industries. He is also frequently involved in IP due diligence and provides litigation support.
Mr Lapointe specialises in genomics, proteomics and pharmaceuticals. He also practises in the agrifood and clean-tech sectors. Before joining Fasken, he was director of intellectual property for public and start-up companies. His industrial experience has made him fully aware of the specific scientific and regulatory aspects of drug development. He brings added value to his clients with his ability to view the technologies presented to him from a corporate perspective.
Mr Lapointe has been recognised for his expertise by the IAM Patent 1000 and is a past winner of the LMG Life Sciences Canadian Patent Non-Contentious Attorney of the Year Award.
Mr Lapointe has considerable experience in assisted reproductive technologies, diseases of the central nervous system, obesity, diabetes, virology, microbiology, genetic markers, blood and nephrological disorders, stem cells, nutraceuticals and green technologies.